Catherine M. Szyman is CVP & Critical Care at Edwards Lifesciences Corp (EW). They have made 52 open-market trades across 2 companies since 2016, most recently 2026-03-11.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $2.7M since 2016, against 50 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EW | SELL | 2024-02-13 | 2024-02-15 | $86.12 | $5.8M | +0.2% | +8.2% | +5.0% |
| EW | SELL · 10b5-1 | 2023-10-10 | 2023-10-10 | $72.68 | $727K | -4.2% | -10.8% | +4.4% |
| EW | SELL · 10b5-1 | 2023-09-08 | 2023-09-08 | $76.00 | $380K | -2.8% | -1.5% | -7.8% |
| EW | SELL · 10b5-1 | 2023-08-09 | 2023-08-09 | $78.64 | $393K | -2.1% | -5.0% | -14.7% |
| EW | SELL · 10b5-1 | 2023-07-10 | 2023-07-10 | $90.52 | $453K | +1.1% | -14.9% | -20.5% |
| EW | SELL · 10b5-1 | 2023-06-13 | 2023-06-13 | $85.81 | $429K | -0.3% | +3.7% | -16.6% |
| EW | SELL · 10b5-1 | 2023-05-09 | 2023-05-09 | $88.94 | $6.7M | -1.4% | -5.9% | -10.5% |
| EW | SELL | 2022-05-04 | 2022-05-05 | $104.87 | $4.9M | -4.9% | -5.9% | +1.0% |
| EW | SELL | 2022-04-11 | 2022-04-11 | $121.82 | $3.6M | -3.2% | -23.7% | -20.8% |
| EW | SELL | 2022-03-14 | 2022-03-14 | $104.65 | $4.2M | +4.5% | +16.4% | -15.4% |
| EW | SELL | 2022-02-18 | 2022-02-18 | $106.32 | $2.1M | +6.7% | +6.2% | -10.1% |
| EW | SELL | 2022-01-14 | 2022-01-14 | $119.53 | $2.4M | -11.3% | -6.3% | +4.4% |
| EW | SELL | 2021-12-17 | 2021-12-17 | $121.24 | $1.2M | +8.5% | -3.8% | -6.6% |
| EW | SELL | 2021-11-18 | 2021-11-19 | $117.79 | $2.4M | -6.4% | +2.2% | -9.0% |
| EW | SELL | 2021-10-18 | 2021-10-18 | $110.41 | $2.2M | +4.0% | +5.6% | +3.4% |
| EW | SELL | 2021-09-08 | 2021-09-08 | $121.28 | $2.4M | -4.0% | -11.5% | -6.0% |
| EW | SELL | 2021-08-02 | 2021-08-02 | $113.53 | $1.7M | -1.4% | +5.4% | +2.0% |
| EW | SELL | 2021-06-15 | 2021-06-15 | $101.17 | $690K | +2.8% | +5.6% | +18.5% |
| EW | SELL | 2021-05-28 | 2021-05-28 | $95.29 | $393K | +3.4% | +6.1% | +21.0% |
| EW | SELL | 2021-05-25 | 2021-05-25 | $96.10 | $897K | -1.0% | +6.7% | +20.2% |
| EW | SELL | 2021-05-07 | 2021-05-07 | $91.87 | $623K | -1.7% | +4.5% | +24.5% |
| EW | SELL | 2021-04-22 | 2021-04-22 | $94.40 | $640K | -3.1% | -0.9% | +10.2% |
| EW | SELL | 2021-03-15 | 2021-03-15 | $81.66 | $553K | -0.9% | +6.1% | +24.2% |
| EW | SELL | 2021-02-16 | 2021-02-16 | $88.20 | $598K | -3.9% | -9.0% | +4.0% |
| EW | SELL | 2021-01-15 | 2021-01-15 | $87.27 | $592K | -6.0% | -1.9% | -0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.